Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-02

Study Completion Date

2027-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical trial is to understand whether oral vitamin C can help delay the aging of middle-aged and elderly individuals, search for sensitive biomarkers of human aging, and provide new paradigms and scientific guidance for aging intervention with small molecule drugs. The main questions it aims to answer are as follows:

* Can oral vitamin C effectively improve the aging-related indicators?
* What is the safety of participants when taking vitamin C supplements?

Researchers will compare vitamin C with a placebo to observe whether vitamin C is effective in intervening in the aging of middle-aged and elderly individuals. Participants need to:

* Take 2 tablets (250mg/tablet) of vitamin C or placebo after breakfast and dinner every day for 12 consecutive months;
* Go to the designated place for a face-to-face follow-up every 6 months and receive a telephone follow-up every 2 months, and pick up subsequent drugs during the follow-up;
* Honestly inform the medication situation during each follow-up;
* Report any discomfort or adverse reactions that occur during the treatment process to the researchers;
* Fill in a questionnaire about their own health status during each follow-up;
* After 6 months and 12 months of intervention, conduct a comprehensive health examination as required, including blood tests and other items.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Vitamin C on Skeletal Muscle

NCT06262711

Healthy

NOT_YET_RECRUITING NA

A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms

NCT06471023

Healthy Pharmacokinetic

COMPLETED NA

Vitamin C's Antioxidant Effects and COPD Prognosis

NCT06664957

COPD (Chronic Obstructive Pulmonary Disease)

NOT_YET_RECRUITING NA

Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

NCT04264533

Vitamin C Pneumonia, Viral Pneumonia, Ventilator-Associated

TERMINATED PHASE2

Effects Of Daily Taurine Intake For 6 Months On Biological Age and Body Metabolism Indicators As Well As Physical Fitness In 55-75-year-old Women And Men

NCT06613542

Taurine Aging, Biological Physical Activity +6 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ageing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vitamin C

Participants will take the synthetic vitamin C twice a day, 500mg per time

Group Type EXPERIMENTAL

Vitamin C

Intervention Type DIETARY_SUPPLEMENT

Participants swallow synthetic vitamin C tablets 500mg with water, twice a day.

Placebo

Participants will take tablets with the same texture, flavor, and appearance as the experimental group twice a day, 500mg per time.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Participants swallow tablets with the same texture, flavor, and appearance as the experimental group 500mg with water, twice a day.

Baseline control

Recruit 100 healthy individual volunteers aged 18 - 70 years old (20 volunteers in the age range of 18 - 30, 20 in 30 - 40, 20 in 40 - 50, 20 in 50 - 60, and 20 in 60 - 70, with an equal number of males and females in each age group) as the baseline control for age-related changes. This group will not receive any intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vitamin C

Participants swallow synthetic vitamin C tablets 500mg with water, twice a day.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Participants swallow tablets with the same texture, flavor, and appearance as the experimental group 500mg with water, twice a day.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 55-65 years (for the experimental and control groups) or 18-70 years (for the baseline control group assessing aging changes).
* Health Status: Deemed to be in good health based on medical evaluation, including medical history, physical examination, laboratory tests, and cardiac monitoring.
* Weight: BMI within the range of 18.5-28 kg/m².
* Informed Consent: Capable of signing the informed consent form and complying with the requirements and restrictions outlined in the study protocol.

Exclusion Criteria

* Disease Status:Uncontrolled medical conditions or any disease that, in the investigator's opinion, may pose an inappropriate risk or contraindication or interfere with the study's objectives, conduct, or evaluation.Severe chronic or acute diseases (e.g., cancer, heart failure, renal insufficiency, COPD, diabetes, active liver disease, metabolic acidosis, poorly controlled hypertension, epilepsy, recent cardiovascular events, inflammatory bowel disease, neurological disorders, infectious diseases, severe autoimmune diseases, etc.).
* Weight: BMI \< 18.5 or BMI \> 28.
* Substance/Alcohol Abuse: Ongoing alcohol or drug abuse, or excessive alcohol consumption.
* Medical History: History of gastrointestinal diseases, hyperuricemia, kidney or urinary tract stones, glucose-6-phosphate dehydrogenase deficiency, or paroxysmal nocturnal hemoglobinuria.
* Allergy: Allergy to vitamin C or any component of its formulation.
* Recent Medication Use: Use of high-dose vitamin C, vitamin E, low-dose aspirin, acarbose, metformin, NMN/NR, or other anti-aging/weight-loss drugs within the past 3 months.
* Informed Consent: Inability to provide informed consent.
* Other: Any physical condition that, in the investigator's opinion, may adversely affect the study process or outcomes.
* Clinical Research Participation: Participation in any other clinical research within 3 months prior to screening or during the study period, or receipt of chemotherapy, radiotherapy, biologic therapy, small-molecule therapeutic agents, or investigational drugs, with incomplete recovery from related side effects (excluding alopecia or potential neuropathy).

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes